Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) of Extraperitoneal Abdominal Disease, is it Appropriate?
We conducted the largest analysis evaluating extraperitoneal cytoreductions, with no significant differences in almost all survival outcomes. We propose that the presence of extraperitoneal abdominal disease is not a contraindication to proceeding with CRS-HIPEC.
Authors
- Edward Allen Levine (ORCID: https://orcid.org/0000-0002-7683-9502)
- Christopher W. Mangieri (ORCID: https://orcid.org/0000-0003-0633-9454)
- Konstantinos I. Votanopoulos
- Perry Shen (ORCID: https://orcid.org/0000-0002-7416-7829)
Institutions
- Atrium Health Wake Forest Baptist (US)
Publication Details
- Journal
- Annals of Surgical Oncology
- Published
- 2025-02-04
- DOI
- https://doi.org/10.1245/s10434-024-16866-6
- Citations
- 1
- Primary Topic
- Intraperitoneal and Appendiceal Malignancies
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- Wake Forest University